Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 1.034
1.
Clin Ter ; 175(3): 163-167, 2024.
Article En | MEDLINE | ID: mdl-38767073

Abstract: The law (No.40/2004) stipulates that consent to Medically Assisted Procreation (MAP) remains irrevocable post ovum fertilization. Cryo-preservation introduces complexities, enabling embryo implantation requests after a couple's separation and the dissolution of the original parenthood plan. Constitutional Court Ruling No.161 in 2023 affirmed that the prohibition of revoking consent to MAP aligns with the Italian Constitution and the jurisprudence of the European Court of Human Rights. This delicate equilibrium of conflicting interests upholds human freedom, allowing consent revocation prior to ovocyte fertilization. Permitting revocation until implantation could inflict more significant harm: the infertile woman can in fact miss the opportunity to become a mother, impacting her psychophysical well-being and freedom of self-determination. Moreover, the embryo loses the chance to live, remaining in cryopreservation, which violates its dignity. Addressing this issue requires thorough communication by medical profession-als to inform couples about the limitations on consent revocation. An element of objectivity in terms of standards and evidence-based guidelines, from which norms must originate, is of utmost importance. Relying on broadly shared rules, especially at the international level, is vital in light of the unremitting scientific advances in MAP, as in other areas of medicine, which will open up new opportunities for which current legal/regulatory frameworks are inadequate.


Reproductive Techniques, Assisted , Humans , Reproductive Techniques, Assisted/legislation & jurisprudence , Reproductive Techniques, Assisted/ethics , Italy , Female , Male , Health Services Accessibility/legislation & jurisprudence , Cryopreservation , Parental Consent/legislation & jurisprudence , Informed Consent/legislation & jurisprudence
2.
J Reprod Immunol ; 163: 104247, 2024 Jun.
Article En | MEDLINE | ID: mdl-38669789

This comprehensive review examines the multifaceted landscape of surrogacy, a revolutionary treatment for infertility. The study examines historical origins, shifting trends, medical considerations, psychological implications, legal complexities, international variations, and ethical dilemmas surrounding surrogacy. With the advent of assisted reproductive technology, gestational surrogacy allows intended parents a genetic connection to their child. Medical facets encompass indications for gestational surrogacy, drawing attention to maternal health risks and infertility factors. Evidence indicates that medical outcomes are comparable to conventional pregnancies, suggesting a viable reproductive solution for intended parents. Due to the complex nature of surrogacy psychological and emotional vulnerability is inevitable; yet studies underscore positive psychological well-being and satisfaction among gestational carriers (GCs), intended parents (IPs) and children. Surrogacy also has many religious dimensions, as each religion has its own perspective on the distinctive process of creating life and its outcomes, such as, the determination of the child's mother according to their beliefs. Legal considerations emerge as a fundamental aspect, with differing regulations globally. The review emphasizes the significance of comprehensive agreements to safeguard the rights and responsibilities of surrogates and IPs. The unique surrogacy laws in Israel serve as a noteworthy example, reflecting a progressive approach that provides a promising template to establish crucial international guidelines on surrogacy. The absence of international consensus necessitates attention from the global community to address key concerns, including the well-being of GCs, legal recognition for IPs, and the child's best interests, with the goal of establishing a universal standard of care in the field.


Reproductive Techniques, Assisted , Surrogate Mothers , Humans , Surrogate Mothers/legislation & jurisprudence , Female , Pregnancy , Reproductive Techniques, Assisted/ethics , Reproductive Techniques, Assisted/legislation & jurisprudence , Infertility/therapy , Parents/psychology , Israel
4.
Reprod Biomed Online ; 48(5): 103764, 2024 May.
Article En | MEDLINE | ID: mdl-38428344

The practice of surrogacy is frequently the subject of media, scientific, social, regulatory and policy attention. Although it is, for many, an accepted form of assisted reproduction for those who would otherwise not be able to have children, surrogacy often generates strong feeling, particularly where there is any possibility of exploitation. Therefore, there is disagreement about how it should be regulated. In some countries, surrogacy is prohibited in any form, although this does not stop people using it. In others, it is unregulated but still practised. In some nations it is regulated in either a 'commercial' or an 'altruistic' model. This review article considers the possible regulatory future of surrogacy, initially from a UK perspective considering a recent review of the legal framework in a country where surrogacy works well (although some cross borders to access it), and then through an assessment of global trends and other national perspectives. It concludes that the international regulation of surrogacy, although potentially desirable, is unlikely. This being the case, it would be preferable for individual nations to regulate surrogacy so it can be undertaken in ways that are safe, ethical and protective of the best interests of children, surrogates, intended parents and families.


Reproductive Techniques, Assisted , Surrogate Mothers , Surrogate Mothers/legislation & jurisprudence , Humans , Female , Pregnancy , Reproductive Techniques, Assisted/trends , Reproductive Techniques, Assisted/legislation & jurisprudence , United Kingdom
6.
JBRA Assist Reprod ; 28(2): 349-352, 2024 Jun 01.
Article En | MEDLINE | ID: mdl-38530764

This comprehensive review delves into the moral and ethical dilemmas surrounding post-mortem sperm retrieval (PMSR) and its implications for creating new individuals. The paper examines the challenges posed by unusual requests for sperm retrieval from the deceased's widow and parents, as well as the broader socio-ethical considerations associated with PMSR. These requests have often been denied due to the absence of established laws and guidelines governing posthumous sperm retrieval and subsequent births, which were once deemed impossible. While some countries have implemented institutional policies to regulate its use to some extent, there remains a lack of standardized rules and procedures for the collection and retrieval of sperm after death. It is essential to introduce institutional guidelines to facilitate requests for assisted reproductive technology (ART) following successful sperm retrieval. Additionally, the development of PMSR legislation is necessary to ensure a proper balance between the moral rights and fundamental rights of the deceased, their family, and any current or future offspring, while providing adequate protection for all parties involved.


Sperm Retrieval , Humans , Male , Sperm Retrieval/ethics , Sperm Retrieval/legislation & jurisprudence , Posthumous Conception/ethics , Posthumous Conception/legislation & jurisprudence , Reproductive Techniques, Assisted/ethics , Reproductive Techniques, Assisted/legislation & jurisprudence
10.
BJOG ; 129(4): 590-596, 2022 Mar.
Article En | MEDLINE | ID: mdl-34532958

Uterus transplantation (UTx) is fast evolving from an experimental to a clinical procedure, combining solid organ transplantation with assisted reproductive technology. The commencement of the first human uterus transplant trial in the United Kingdom leads us to examine and reflect upon the legal and regulatory aspects closely intertwined with UTx from the process of donation to potential implications for fertility treatment and the birth of the resultant child. As the world's first ephemeral transplant, the possibility of organ restitution requires consideration and is discussed herein. TWEETABLE ABSTRACT: Uterine transplantation warrants a closer look at the legal frameworks on fertility treatment and transplantation in England.


Organ Transplantation/legislation & jurisprudence , Uterus/transplantation , England , Female , Humans , Hysterectomy/legislation & jurisprudence , Hysterectomy/psychology , Reproductive Techniques, Assisted/legislation & jurisprudence , Tissue and Organ Procurement/legislation & jurisprudence
11.
Femina ; 50(5): 296-300, 2022.
Article Pt | LILACS | ID: biblio-1380708

O Conselho Federal de Medicina acaba de editar a Resolução nº 2.294/2021, publicada em 15 de junho de 2021, que aponta normas para a utilização das técnicas de reprodução assistida. Apesar de o propósito ser o aperfeiçoamento das práticas e a observância aos princípios éticos e bioéticos para trazer maior segurança e eficácia a tratamentos e procedimentos médicos, repete inconstitucionalidades das normatizações pretéritas e impõe mais restrições ao sonho das pessoas de ter filhos. Desse modo, mais do que avanços, o novo regramento provoca um retrocesso que não se coaduna com a garantia constitucional e legal que assegura o livre planejamento familiar.(AU)


The Brazilian Federal Council of Medicine has just edited the Resolution nº 2.294/2021, published on June 15, 2021, which sets out rules for the use of assisted reproduction techniques. Although the purpose is to improve practices and observe ethical and bioethical principles to bring greater safety and efficacy to medical treatments and procedures, it repeats the unconstitutionalities of past regulations and imposes more restrictions on people's dreams of having children. In this way, more than advances, the new regulation provokes a setback that is not consistent with the constitutional and legal guarantees of free family planning.(AU)


Humans , Male , Female , Pregnancy , Professional Review Organizations/legislation & jurisprudence , Reproductive Techniques, Assisted/legislation & jurisprudence , Reproductive Techniques, Assisted/ethics , Brazil , Constitution and Bylaws , Resolutions/legislation & jurisprudence , Reproductive Rights , Family Development Planning
12.
Reprod Biomed Online ; 43(3): 571-576, 2021 Sep.
Article En | MEDLINE | ID: mdl-34332903

Access to assisted reproductive technology (ART) and fertility preservation remains restricted in middle and low income countries. We sought to review the status of ART and fertility preservation in Brazil, considering social indicators and legislative issues that may hinder the universal access to these services. Although the Brazilian Constitution expressly provides the right to health, and ordinary law ensures the state is obliged to support family planning, access to services related to ART and fertility preservation is neither easy nor egalitarian in Brazil. Only a handful of public hospitals provide free ART, and their capacity far from meets demand. Health insurance does not cover ART, and the cost of private care is unaffordable to most people. Brazilian law supports, but does not command, the state provision of ART and fertility preservation to guarantee the right to family planning; therefore, the availability of state-funded treatments is still scarce, reinforcing social disparities. Economic projections suggest that including ART in the Brazilian health system is affordable and may actually become profitable to the state in the long term, not to mention the ethical imperative of recognizing infertility as a disease, with no reason to be excluded from a health system that claims to be 'universal'.


Fertility Preservation , Health Services Accessibility , Reproductive Techniques, Assisted , Brazil , Family Planning Services/economics , Family Planning Services/ethics , Family Planning Services/legislation & jurisprudence , Female , Fertility Preservation/ethics , Fertility Preservation/legislation & jurisprudence , Health Services Accessibility/ethics , Health Services Accessibility/legislation & jurisprudence , Healthcare Disparities/ethics , Healthcare Disparities/legislation & jurisprudence , Humans , Infant, Newborn , Infertility/economics , Infertility/epidemiology , Infertility/therapy , Male , Pregnancy , Reproductive Rights/ethics , Reproductive Rights/legislation & jurisprudence , Reproductive Techniques, Assisted/economics , Reproductive Techniques, Assisted/ethics , Reproductive Techniques, Assisted/legislation & jurisprudence
13.
Reprod Biomed Online ; 43(3): 421-433, 2021 Sep.
Article En | MEDLINE | ID: mdl-34344602

Infertility is a medico-socio-cultural problem associated with gender-based suffering. Infertility treatment, including assisted reproductive technology (ART), is a human right. Culture and religion were among the stumbling blocks to early acceptance of ART, particularly in the Middle East and to a lesser extent in Europe. This was mostly due to the different cultural and religious perspectives on the moral status of the embryo in the two regions and the concerns about what could be done with human embryos in the laboratory. There is an increased demand for ART in both the Middle East and Europe, although the reasons for this increased demand are not always the same. Although Europe leads the world in ART, there is an unmet need for ART in many countries in the Middle East. Where ART is not supported by governments or insurance companies, a large percentage of couples paying for ART themselves will stop before they succeed in having a baby. There are similarities and differences in ART practices in the two regions. If a healthcare provider has a conscientious objection to a certain ART modality, he/she is ethically obliged to refer the patient to where they could have it done, provided it is legal.


Culture , Infertility/therapy , Religion and Medicine , Reproductive Techniques, Assisted , Europe/epidemiology , Female , Humans , Infant, Newborn , Infertility/epidemiology , Infertility/psychology , Male , Middle East/epidemiology , Pregnancy , Religion , Reproductive Techniques, Assisted/legislation & jurisprudence , Reproductive Techniques, Assisted/psychology , Social Stigma
14.
Clin Ter ; 172(4): 253-255, 2021 Jul 05.
Article En | MEDLINE | ID: mdl-34247204

ABSTRACT: Law No 40/2004 regulates in Italy the matter of medically assisted procreation (MAP). Recently, the Tribunal of Capua Vetere expressed its position on the subject of informed consent in a case of MAP. In the specific case, a couple entered the preliminary stages of the PMA procedures, carrying out the fertilization of the ovum and the embryo production. Afterwards, the couple separated and the man denied consent to the continuation of the MAP. The woman, willing to proceed with the implantation, the woman made an urgent judicial appeal, obtaining the judge's permission to transfer the embryo to the uterus. This paper analyses the different bioethical positions on MAP's informed consent. In fact, on the one hand, the paper highlight what is set out in Law 219/2017 which provides for the possibility of the patient to revoke at any time the consent to the treatment given. On the other hand, it should be noted that Law 40/2004, willing to protect the embryo, establishes the irrevocability of the position of parental consent after fertilization. The judgment in question seems to favour this latter position, placing itself in the protection of the cryopreserved embryo and recall-ing the principle of entrustment following the fertilization of the egg. Nevertheless, the matter is controversial a consistent amount of legal developments are expected to arise in the next future.


Embryo Implantation , Informed Consent/ethics , Informed Consent/legislation & jurisprudence , Informed Consent/standards , Reproductive Techniques, Assisted/ethics , Reproductive Techniques, Assisted/legislation & jurisprudence , Reproductive Techniques, Assisted/standards , Adult , Divorce/legislation & jurisprudence , Embryo, Mammalian , Female , Humans , Italy , Male , Parents
15.
Fertil Steril ; 116(4): 1119-1125, 2021 10.
Article En | MEDLINE | ID: mdl-34246467

OBJECTIVE: To examine infertility-related fund-raising campaigns on a popular crowdfunding website and to compare campaign characteristics across states with and without legislative mandates for insurance coverage for infertility-related care. DESIGN: Retrospective cohort study. SETTING: Online crowdfunding platform (GoFundMe) between 2010 and 2020. PATIENT(S): GoFundMe campaigns in the United States containing the keywords "fertility" and "infertility." INTERVENTION(S): State insurance mandates for infertility treatment coverage. MAIN OUTCOME MEASURE(S): Primary outcomes included fund-raising goals, funds raised, campaign location, and campaigns per capita. RESULT(S): Of the 3,332 infertility-related campaigns analyzed, a total goal of $52.6 million was requested, with $22.5 million (42.8%) successfully raised. The average goal was $18,639 (standard deviation [SD] $32,904), and the average amount raised was $6,759 (SD $14,270). States with insurance mandates for infertility coverage had fewer crowdfunding campaigns per capita (0.75 vs. 1.15 campaigns per 100,000 population than states without insurance mandates. CONCLUSION(S): We found a large number of campaigns requesting financial assistance for costs associated with infertility care, indicating a substantial unmet financial burden. States with insurance mandates had fewer campaigns per capita, suggesting that mandates are effective in mitigating this financial burden. These data can inform future health policy legislation on the state and federal levels to assist with the financial burden of infertility.


Crowdsourcing/economics , Health Care Costs , Health Expenditures , Infertility/economics , Infertility/therapy , Insurance Coverage/economics , Insurance, Health/economics , Reproductive Techniques, Assisted/economics , State Health Plans/economics , Crowdsourcing/legislation & jurisprudence , Eligibility Determination/economics , Female , Government Regulation , Health Care Costs/legislation & jurisprudence , Health Expenditures/legislation & jurisprudence , Health Services Needs and Demand/economics , Humans , Infertility/diagnosis , Insurance Coverage/legislation & jurisprudence , Insurance, Health/legislation & jurisprudence , Male , Needs Assessment/economics , Reproductive Techniques, Assisted/legislation & jurisprudence , Retrospective Studies , State Health Plans/legislation & jurisprudence , United States
17.
Am J Obstet Gynecol ; 225(3): 264-269, 2021 09.
Article En | MEDLINE | ID: mdl-33839094

Gestational surrogacy in the United States has quadrupled since 1999, but to date, only a few states explicitly permit compensated gestational surrogacy. Current legal prohibitions are often influenced by outdated and stereotyped understandings of surrogacy. It is increasingly important to understand the current literature about the medical and mental health impacts of surrogacy and how state legislatures have addressed compensated gestational surrogacy in recent years. Based on this review, we found no evidence of substantial adverse medical or psychological outcomes among women who are gestational carriers or among the children they give birth to. The literature suggests that gestational surrogacy is a safe and increasingly popular option for families as long as rigorous screening and medical, psychological, and social supports are equitably provided. As states move to responsibly legalize and regulate gestational surrogacy, there is a continued need for further longitudinal studies on the health and psychological outcomes of gestational surrogacy.


Pregnancy Outcome , Surrogate Mothers , Female , Humans , Parent-Child Relations , Pregnancy , Pregnancy, Multiple , Reproductive Techniques, Assisted/legislation & jurisprudence , Reproductive Techniques, Assisted/psychology , Surrogate Mothers/legislation & jurisprudence , Surrogate Mothers/psychology
18.
Med Leg J ; 89(2): 128-132, 2021 Jun.
Article En | MEDLINE | ID: mdl-33715522

Transnational commercial surrogacy is a form of medical tourism undertaken by intended parents in an attempt to seek surrogates in other countries. Most intended parents are from developed countries and seek their surrogates from developing countries, predominantly from South and Southeast Asia. This arrangement led to the establishment of surrogacy businesses in South and Southeast Asia, in countries such as India and Thailand. Subsequently, the business was banned in these countries, which led to a trend of moving it to neighbouring countries where there were no regulations or restrictions. This paper maps the movement of the industry and calls for attention to re-consider or re-frame commercial surrogacy in an international framework.


Commerce/economics , Commerce/legislation & jurisprudence , Reproductive Techniques, Assisted/legislation & jurisprudence , Surrogate Mothers/legislation & jurisprudence , Asia, Southeastern , Asia, Western , Commerce/trends , Female , Humans , Pregnancy
19.
Fertil Steril ; 115(2): 268-273, 2021 02.
Article En | MEDLINE | ID: mdl-33579520

This article provides a general overview of the practical management of legal issues in cross-border gestational surrogacy. Particular problems arising from the global pandemic as well as a number of proposed solutions are presented and analyzed. A section addressing the involvement of the fertility center in such arrangements is included. Additionally, the article discusses how parentage and citizenship are handled abroad, with a focus on the United Kingdom.


Emigration and Immigration/legislation & jurisprudence , Internationality , Reproductive Techniques, Assisted/legislation & jurisprudence , Surrogate Mothers/legislation & jurisprudence , Emigration and Immigration/trends , Female , Humans , Pregnancy , Reproductive Techniques, Assisted/trends , United Kingdom/epidemiology
20.
Fertil Steril ; 115(2): 274-281, 2021 02.
Article En | MEDLINE | ID: mdl-33579521

Cryopreservation of reproductive material has dramatically improved clinical outcomes for patients all over the world. At the same time the practice has produced significant legal, ethical, and practical challenges to physicians and practices who use this technique. Failing to meet the expectations of patients, for example by losing material because of a freezer failure, has significant implications for the reproductive facility. Similarly, improperly transporting or receiving gametes or embryos can result in substantial risk to a practice. Perhaps the most widely publicized conundrum is how best to manage embryos that are abandoned. This paper will describe the legal principles and best practices that should be incorporated into the management of a fertility cryopreservation program.


Cryopreservation/methods , Embryo Disposition/legislation & jurisprudence , Fertility Clinics/legislation & jurisprudence , Germ Cells/physiology , Reproductive Techniques, Assisted/legislation & jurisprudence , Cryopreservation/standards , Embryo Disposition/standards , Fertility Clinics/standards , Humans , Reproductive Techniques, Assisted/standards , Specimen Handling/standards
...